TrialJournal of neuro-oncology2017
A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas.
Stéphane Goutagny et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papertrialcites it
TrialJournal of neuro-oncology2017
Stéphane Goutagny et al.PubMed ↗Publisher ↗
No numbers read from the abstract.